Cargando…

Markers of exacerbation severity in chronic obstructive pulmonary disease

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) can experience 'exacerbations' of their conditions. An exacerbation is an event defined in terms of subjective descriptors or symptoms, namely dyspnoea, cough and sputum that worsen sufficiently to warrant a change in m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franciosi, Luigi G, Page, Clive P, Celli, Bartolome R, Cazzola, Mario, Walker, Michael J, Danhof, Meindert, Rabe, Klaus F, Pasqua, Oscar E Della
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1481583/ https://www.ncbi.nlm.nih.gov/pubmed/16686949 http://dx.doi.org/10.1186/1465-9921-7-74

Ejemplares similares

The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experiments
por: Sahota, Tarjinder, et al.
Publicado: (2015)

Characterizing QT interval prolongation in early clinical development: a case study with methadone
por: Dubois, Vincent F. S., et al.
Publicado: (2017)

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2015)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
por: Cazzola, Mario, et al.
Publicado: (2023)

Prediction of Disease Progression, Treatment Response and Dropout in Chronic Obstructive Pulmonary Disease (COPD)
por: Musuamba, F. T., et al.
Publicado: (2014)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey
por: Barnes, Neil, et al.
Publicado: (2013)

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2022)

Model-Based Optimisation of Deferoxamine Chelation Therapy
por: Bellanti, Francesco, et al.
Publicado: (2015)

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
por: Cazzola, Mario, et al.
Publicado: (2015)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models
por: Danhof, Meindert
Publicado: (2015)

From Laënnec’s Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome
Publicado: (2023)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease
por: Celli, Bartolome R, et al.
Publicado: (2012)

Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm
por: Taneja, A., et al.
Publicado: (2017)

Hyperglycaemia and Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2023)

Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
por: Celli, Bartolome R., et al.
Publicado: (2023)

Doxofylline is not just another theophylline!
por: Matera, Maria Gabriella, et al.
Publicado: (2017)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease
por: Hernández Cordero, Ana I., et al.
Publicado: (2021)

Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Su, Linfan, et al.
Publicado: (2022)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
por: Matera, Maria Gabriella, et al.
Publicado: (2016)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset
por: Calverley, Peter M A, et al.
Publicado: (2022)

Long-acting β(2)-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety
por: Rossi, Andrea, et al.
Publicado: (2008)

Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease
por: de Torres, Juan P, et al.
Publicado: (2007)

A combined phase I/IIa study of the safety, bronchodilator and bronchoprotective effects of nebulized RPL554, a dual PDE3/4-inhibitor, in healthy subjects and asthmatics
por: Franciosi, Luigi, et al.
Publicado: (2013)

Reply to Pouwels et al.: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Stockley, Robert A., et al.
Publicado: (2019)

Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease
por: Santibáñez, Miguel, et al.
Publicado: (2016)

Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Córdoba-Lanús, Elizabeth, et al.
Publicado: (2023)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Acute Exacerbations
por: Wedzicha, J.A., et al.
Publicado: (2006)

Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Segal, Leopoldo N., et al.
Publicado: (2015)

Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Publicado: (2007)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease
por: Kelly, Emer, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iv3e0ibf5nmtd1ta3gajghkom1